Journal
CHEMICAL COMMUNICATIONS
Volume 52, Issue 15, Pages 3155-3158Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5cc09718e
Keywords
-
Categories
Funding
- National Cancer Institute (NCI) [1SC1CA182844]
- Tow Foundation
- NATIONAL CANCER INSTITUTE [SC1CA182844] Funding Source: NIH RePORTER
Ask authors/readers for more resources
We describe a versatile and quick route to cationic gold(I) complexes containing N-heterocyclic carbenes and a second ancillary ligand (such as phosphanes, phosphites, arsines and amines) of interest for the synthesis of compounds with potential catalytic and medicinal applications. The general synthetic strategy has been applied in the preparation of novel cationic heterobimetallic ruthenium(II)-gold(I) complexes that are highly cytotoxic to renal cancer Caki-1 and colon cancer HCT 116 cell lines while showing a synergistic effect and being more selective than their monometallic counterparts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available